Merck

Inspire's Pink Eye Drug AzaSite Draws Generic Challenge
Motley Fool
Wed, 04/27/11 - 11:31 am
Inspire
generics
Azasite
Merck
pink eye
Merck: Earnings Preview
Yahoo/Zacks.com
Wed, 04/27/11 - 11:17 am
Merck
earnings
5 Large Cap Pharmas - Proceed With Caution
Seeking Alpha
Wed, 04/27/11 - 11:16 am
JNJ
Eli Lilly
Merck
Novartis
Sanofi
Merck: FDA Hep C Panel Live Blog
TheStreet.com
Wed, 04/27/11 - 11:11 am
Merck
advisory panels
FDA
hepatitis C
Vertex Pharmaceuticals
Boceprevir
Merck, Qiagen Begin Rwandan Cervical-Cancer Program, Times Says
Bloomberg
Tue, 04/26/11 - 06:17 am
Merck
cervical cancer
Qiagen
Rwanda
HPV
Gardasil
vaccines
Vertex, Merck Step Up to the Public Stage With Hepatitis C Drugs This Week
Motley Fool
Mon, 04/25/11 - 11:15 am
Vertex Pharmaceuticals
Merck
Boceprevir
Telaprevir
hepatitis C
Sun Pharma to sell some Merck diabetes drugs in India
Reuters
Mon, 04/25/11 - 09:21 am
Merck
diabetes
India
Sun Pharma
FDA says highly anticipated Merck drug achieved goal of eliminating traces of hepatitis C
Yahoo/AP
Mon, 04/25/11 - 09:17 am
Merck
FDA
hepatitis C
Boceprevir
Merck's Risky Bet on Research
Bloomberg
Sat, 04/23/11 - 10:51 am
Merck
R&D
Crunching the Data: Seven Big Pharmas With Consistent Dividends
Seeking Alpha
Sat, 04/23/11 - 10:50 am
Bristol-Myers Squibb
Abbott Laboratories
JNJ
AstraZeneca
Eli Lilly
Merck
Merck's Risky Bet on Research
Businessweek
Fri, 04/22/11 - 07:56 am
Merck
R&D
Crunching the Data: Seven Big Pharmas With Consistent Dividends
Seeking Alpha
Fri, 04/22/11 - 07:54 am
dividends
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
JNJ
Eli Lilly
Merck
Novartis
How Do These Pharmas Really Boost Their Returns?
Motley Fool
Thu, 04/21/11 - 10:56 am
Merck
Pfizer
Abbott Laboratories
GSK
ROE
Merck, Vertex Prep for Hep C Drug Panels
TheStreet.com
Thu, 04/21/11 - 09:21 am
Merck
Vertex Pharmaceuticals
hepatitis C
FDA
Boceprevir
Telaprevir
advisory panels
Relief as Merck, J&J Reach Happy Compromise
Seeking Alpha
Sun, 04/17/11 - 11:26 am
Merck
JNJ
Dark Clouds Lift Over Pharma Dispute
Motley Fool
Sat, 04/16/11 - 01:27 pm
Merck
Schering Plough
JNJ
Remicade
Simponi
Merck Eases Investors’ Minds, At A Cost
Forbes
Fri, 04/15/11 - 11:19 am
Merck
investors
Merck Keeps Limited Rights to Share of J&J’s Sales of Remicade Medicine
Bloomberg
Fri, 04/15/11 - 09:48 am
JNJ
Remicade
Merck
Former Merck CEO Clark received 65 percent increase in total compensation last year
Yahoo/AP
Thu, 04/14/11 - 11:51 am
Richard Clark
executive pay
Merck
Vertex Receives Good News on Hepatitis C Treatment
Seeking Alpha
Thu, 04/14/11 - 11:01 am
Vertex Pharmaceuticals
hepatitis C
Telaprevir
Merck
bacepravir
Victrella

Pages